Literature DB >> 12638383

Psychological adjustment to the melanoma experience.

Deborah A Boyle1.   

Abstract

OBJECTIVES: To provide a review of the literature on the psychological adjustment to malignant melanoma. DATA SOURCES: Research reports and review articles.
CONCLUSIONS: Three prominent themes evolved from the literature: (1) delineation of issues concerning long-term survivorship and quality of life following a diagnosis of melanoma; (2) coping with metastatic and end-stage melanoma; and (3) identification of the possible link between immunomodulation and the evolution of melanoma. IMPLICATIONS FOR NURSING PRACTICE: Oncology nurses must individualize their support and counsel according to the potential trajectory of the patient's melanoma experience. Nurses need to identify an individual's risk for psychological distress and help them enhance coping skills.

Entities:  

Mesh:

Year:  2003        PMID: 12638383     DOI: 10.1053/sonu.2003.50006

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  8 in total

1.  Association of Quality of Life With Surgical Excision of Early-Stage Melanoma of the Head and Neck.

Authors:  Shoko Mori; Nina R Blank; Karen L Connolly; Stephen W Dusza; Kishwer S Nehal; Anthony M Rossi; Erica H Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Health behaviors and needs of melanoma survivors.

Authors:  Oxana Palesh; Arianna Aldridge-Gerry; Kelly Bugos; David Pickham; Jie Jane Chen; Ralph Greco; Susan M Swetter
Journal:  Support Care Cancer       Date:  2014-05-31       Impact factor: 3.603

3.  Melanoma survivorship: research opportunities.

Authors:  Susan A Oliveria; Jennifer L Hay; Alan C Geller; Maureen K Heneghan; Mary S McCabe; Allan C Halpern
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

4.  Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment.

Authors:  Dennis A Revicki; Alfons J M van den Eertwegh; Paul Lorigan; Celeste Lebbe; Gerald Linette; Christian H Ottensmeier; Shima Safikhani; Marianne Messina; Axel Hoos; Samuel Wagner; Srividya Kotapati
Journal:  Health Qual Life Outcomes       Date:  2012-06-13       Impact factor: 3.186

Review 5.  Emerging options for the treatment of melanoma - focus on ipilimumab.

Authors:  Claire Roddie; Karl S Peggs
Journal:  Immunotargets Ther       Date:  2014-03-17

6.  Feasibility of an online mindfulness-based program for patients with melanoma: study protocol for a randomised controlled trial.

Authors:  Lahiru Russell; Anna Ugalde; Donna Milne; Meinir Krishnasamy; Eric O Seung Chul; David W Austin; Richard Chambers; Liliana Orellana; Patricia M Livingston
Journal:  Trials       Date:  2018-04-13       Impact factor: 2.279

7.  Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors.

Authors:  Sabine Fischbeck; Veronika Weyer-Elberich; Sylke R Zeissig; Barbara H Imruck; Maria Blettner; Harald Binder; Manfred E Beutel
Journal:  BMC Public Health       Date:  2018-04-17       Impact factor: 3.295

Review 8.  A systematic review of health-related quality of life in cutaneous melanoma.

Authors:  D Cornish; C Holterhues; L V van de Poll-Franse; J W Coebergh; T Nijsten
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.